Description
| Format | Cassette | Package | Cartons |
| Specimen | WB/S/P | Certificate | CE ISO 13485 |
| Storage Temperature | 4-30°C | Pack | 40T |
| Test Time | 15 min | Shelf life | 2 years |
| Sensitivity | >98% | OEM&ODM | Available |
Intended UseThe One Step CEA Carcinoembryonic Antigen Test (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of CEA in whole blood, serum or plasma to aid in monitoring of cancer patientsSummaryCarcinoembryonic Antigen (CEA) is a cell surface glycoprotein of approximately 20,000 molecular weight. CEA is a blood-born protein that was firstly noted as a specific antigen for adenocarcinoma of the colon. Further investigations showed that CEA can presence in a variety of cancers other than colonic, including pancreatic, gastric, lung, and breast etc. Small amounts have also been demonstrated in secretions from the colonic mucosa. Additionally, CEA-like substances have been reported in normal bile from non-icteric patients. The normal CEA concentration in human blood is <2.5 ng/mL in an adult non-smoker and <5.0 ng/mL in a smoker. CEA tests can have significant value in the monitoring of patients. Progressive
elevations of CEA may herald tumor recurrence 3-36 months before clinical evidence of metastases. Persistent elevation in circulating CEA following treatment is strongly indicative of occult metastatic and/or residual disease. A persistent rising CEA value may be associated with progressive malignant disease and poor therapeutic response. A declining CEA value is generally indicative of a favorable prognosis and good response to treatment. Measurement of CEA has been shown to be clinically relevant in the follow-up management of patients with colorectal, breast, lung, prostatic, pancreatic, ovarian, and other carcinomas. Follow-up studies of patients with colorectal, breast and lung carcinomas suggest that the preoperative CEA level has prognostic significance. CEA testing is not recommended as a screening procedure to detect cancer in the general population; however, use of the CEA test as an adjunctive test in the prognosis and management of cancer patients is widely accepted. The minimum detection level is 5 ng/mLFAQQ: Are you a trading company or manufacturer?
A: We are a manufacturer that focusing on the development and manufacturing of diagnostic equipment.
Q:What other products do you have?
A:We supply Infectious Disease Rapid Test,Hormone Rapid Test,Cardiac Markers Rapid Test,Tumor Markers Rapid Test,Drug of abuse Rapid Test and Veteinary Diagnostc Rapid Test.If you want a product catalog, pls feel free to contact me. And we also support exporting materials if needed.
Q: Is free sample available?
A: Yes, we are glad to offer you some samples for free, but freight shall be collected at your side.
Complaint
